Urb2 as an important marker for glioma prognosis and immunotherapy

HIGHLIGHTS

SUMMARY

    Glioma accounts for approximately thirty percent of brain tumors and eighty percent of malignant brain tumors and is the most frequent primary brain tumor (Omuro and DeAngelis, 2013; Ostrom et_al, 2015). According to the criteria of the World Health Organization (WHO), glioma is classified into four different groups, which are associated with malignancy (Ostrom et_al, 2017; Wesseling and Capper, 2018). TGF-beta acts as a cancer suppressor in the initial stage of tumorigenesis (de Caestecker et_al, 2000; Zhang et_al, 2017; Chandra Jena et_al, 2021). Nomograms are often used in various cancer types to intuitively . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?